Guidance on COVID-19 Vaccination

The Add-Aspirin Trial Management Group encourages everyone on the Add-Aspirin trial to have a Covid vaccine if they are advised to do so by their hospital doctor or GP. Add-Aspirin trial participants should tell the nurse or doctor that administers the vaccine that they may be receiving aspirin. There can be some bruising associated with an intramuscular injection. Add-Aspirin trial participants who are already experiencing any bruising or minor bleeding should inform the vaccination team before the vaccination is administered. Add-Aspirin trial medication can be withheld (for example 5 days either side of the vaccination) if there are any specific concerns.

Contact Details

If you are an individual who is interested in taking part in Add-Aspirin, please talk to your doctor who will be able to consider whether you are suitable for the trial.

For healthcare professionals

Please log into the members area for Add-Aspirin contact details.

Register Interest

For healthcare professionals

If your centre would like to recruit participants to Add-Aspirin, contact us:
mrcctu.add-aspirin@ucl.ac.uk

Register a participant

From Monday 16th March 2020, to RANDOMISE a participant in the UK please call +44 (0)20 7670 4925, rather than the usual randomisation line.

To RANDOMISE a participant from Republic of Ireland or India only, please use the 'Register a participant' link above to randomise online. Please make sure to press 'Randomise' once logged in to the server.

We have been experiencing intermittent issues with the trial websites. In the event of an emergency unblinding outside of office hours (including over the Easter bank holidays), if the usual unblinding links are not working, please telephone +(0)20 7670 4906 or +(0)20 7670 4892 to reach one of the Trial Managers.

Unblind a participant in the UK

Unblind a participant in the RoI

Unblind a participant in India